Vitex⁴ Equids

Vitex⁴ Equids is an aqueous extract of the herb Vitex agnus castus (also known as Monk's Pepper or Chasteberry; part of the vervain family of plants. Vitex is a shrub grown widely along the river banks and in the valleys of the Mediterranean and Central Asiatic regions. After flowering in high summer, the plant develops dark brown fruit [similar to peppercorns]. These fruits are dried and are the parts of the plant used in the preparation of Vitex⁴ Equids.

Vitex⁴ Equids is based on purified water, with no chemical additives nor inclusions and is 100% natural. Vitex⁴ Equids can therefore be used in competition animals.

Vitex⁴ Equids is unique among herbal infusions in terms of the quality control procedures used during its preparation. Vitex⁴ Equids is made in a laboratory licenced under the UK Medicines Acts 1968 and 1971. This ensures an exceptionally high level of quality and conformity; the same quality as is necessary to produce the drugs you are prescribed from your doctor.

Vitex⁴ Equids can

1) be fed to horses with Cushing's disease
2) control aggressive or uncooperative behaviour in all equids
3) help the mare to cycle regularly and show oestrus behaviour when she is in season so that "silent heats" are not missed
4) help maintain the optimal progesterone concentrations, particularly in the early stages of pregnancy
5) control aggressive behaviour when the mare is in season
6) encourage mares to establish regular cycles early in the breeding season
7) maintain excellent sperm quality in stallions
8) provide a sense of well being in equids

How does Vitex⁴ Equids work?

A large amount of research on Vitex has been carried out in Germany and according to Dr Rudolf Fritz Weiss, Vitex acts on the hypothalamus and pituitary gland. The pituitary gland is the "conductor of the hormonal orchestra" governing digestion, metabolic rate, reproduction, behaviour, growth and ageing.

It is known that Vitex can support the hormonal balance in horses.

Click here to view further information on Vitex collected during a study conducted by The Laminitis Trust